Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Severe Asthma in Children

Severe Asthma in Children Curr Allergy Asthma Rep (2017) 17: 21 DOI 10.1007/s11882-017-0688-z PEDIATRIC ALLERGY AND IMMUNOLOGY (W DOLEN, SECTION EDITOR) 1 1 1 Bradley E. Chipps & Neil G. Parikh & Sheena K. Maharaj Published online: 28 March 2017 Springer Science+Business Media New York 2017 Abstract persistent. Currently, available treatments have not been Purpose of Review The aim of this study is to characterize, shown to provide disease modification. diagnose, evaluate, and treat severe childhood asthma. Recent Findings Understanding the occurrence of the physi- ologic and clinical presentations of childhood severe asthma, Natural History of Severe Asthma the treatment and response may be predicted by biomarkers, but the patient’s response is highly variable. Asthmaaffectsnearly6millionchildrenintheUSA Summary The onset of severe asthma occurs early and is pri- approximately 10% of children less than 15 years of marily predicted by severity of viral infection and coexistence age. A total of 5–10% of these children have severe or of the atopic state. difficult-to-treat asthma. The medical expenditure for asthma is approximately 10 billion annually with severe . . . Keywords Severe asthma Childhood asthma Biomarkers asthma accounting for up to 50% of these costs. The Biologic therapy Pharmacologic therapy National Heart, Lung and Blood Institute’sSevere Asthma http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Allergy and Asthma Reports Springer Journals

Loading next page...
 
/lp/springer-journals/severe-asthma-in-children-TkWyaN61tE

References (80)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Allergology
ISSN
1529-7322
eISSN
1534-6315
DOI
10.1007/s11882-017-0688-z
pmid
28353215
Publisher site
See Article on Publisher Site

Abstract

Curr Allergy Asthma Rep (2017) 17: 21 DOI 10.1007/s11882-017-0688-z PEDIATRIC ALLERGY AND IMMUNOLOGY (W DOLEN, SECTION EDITOR) 1 1 1 Bradley E. Chipps & Neil G. Parikh & Sheena K. Maharaj Published online: 28 March 2017 Springer Science+Business Media New York 2017 Abstract persistent. Currently, available treatments have not been Purpose of Review The aim of this study is to characterize, shown to provide disease modification. diagnose, evaluate, and treat severe childhood asthma. Recent Findings Understanding the occurrence of the physi- ologic and clinical presentations of childhood severe asthma, Natural History of Severe Asthma the treatment and response may be predicted by biomarkers, but the patient’s response is highly variable. Asthmaaffectsnearly6millionchildrenintheUSA Summary The onset of severe asthma occurs early and is pri- approximately 10% of children less than 15 years of marily predicted by severity of viral infection and coexistence age. A total of 5–10% of these children have severe or of the atopic state. difficult-to-treat asthma. The medical expenditure for asthma is approximately 10 billion annually with severe . . . Keywords Severe asthma Childhood asthma Biomarkers asthma accounting for up to 50% of these costs. The Biologic therapy Pharmacologic therapy National Heart, Lung and Blood Institute’sSevere Asthma

Journal

Current Allergy and Asthma ReportsSpringer Journals

Published: Mar 28, 2017

There are no references for this article.